drugset / Trial / NCT06186895

Dexmedetomidine Versus Fentanyl on Postoperative Analgesic Profile in Laparoscopic Sleeve Gastrectomy

NCT06186895 ↗

Completed 64 enrolled Helwan University
RandomizedParallel-groupDouble-blindTreatment

Summary

Dexmedetomidine (Dex) activates the α2 adrenergic receptor that is present within the locus coeruleus, leading to anxiolysis, hypnosis, analgesia, and sedation. We conducted our research to compare the effects of fentanyl and DEX on the postoperative analgesic profile and complications in morbidly obese patients after sleeve gastrectomy.

Timeline

Start
2021-07-20
Primary completion
2023-05-20
Completion
2023-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.6 ug/kg Intravenous
Comparator Fentanyl Other / unclassified 1 ug/kg Intravenous

Indications